Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second Autologous Transplantation in AL Amyloidosis
NCT00075608Phase 2Terminated
- Sponsor
- Boston Medical Center
- Start
- Aug 2001
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in amyloid light chain amyloidosis, sponsored by Boston Medical Center. Started Aug 2001; status: terminated.
02
Drugs
melphalan
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT00075608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075608.